RxDoctor Payments Data

Braden Thomas

Hepatology · Baltimore, MDNPI 1215515473

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,775 of the $4,521 with a category attached, or 83.5%. 21 manufacturers reported payments, led by Boston Scientific at 42.8% of the total.

$4,521in general payments, 2019–2025

Across 79 payments — averaging $57.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Madrigal Pharmaceuticals$1K
  • Gilead$336
  • Mallinckrodt Hospital Products Inc.$235
  • AbbVie$190
  • Takeda Pharmaceuticals U.S.A., Inc.$157
  • plus $579 from 15 others
$24,871in research payments, 2019–2025

Across 6 payments — averaging $4145.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Travere Therapeutics, Inc.$25K

What the payments were for

  • Travel & lodging$74616%
  • Food & beverage$3,77584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hepatology providers in Marylandto place this figure against a meaningful peer group, so we don't.

Other hepatology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →